Multimodal imaging revealed Bietti crystalline dystrophy in a young adult, confirmed by CYP4V2 mutation. Discover how SD-OCT and FAF guided this rare diagnosis.
Details: https://t.co/n4864ON6js
Most OD–MD referral relationships rely on proximity rather than systems and intention. Diana Canto-Sims, OD, Kevin J. Kovach, MD, and Giannie Castellanos, OD outline five pillars for building partnerships that actually protect patients.
Read more here: https://t.co/iYDTpk7yjM
Physical activity reduces glaucoma risk by 47% and diabetic retinopathy progression by 32%, yet exercise rarely comes up at the eye exam. A. Paul Chous, OD, MA, FAAO makes the evidence-based case for changing that.
Read more: https://t.co/CGb70dIUBp
Day 1 at AOA was full of great conversations with leading ODs covering everything from contact lens innovation to clinical practice updates. Thank you to all who shared their insights with us—full interviews coming soon 👁️
Read coverage here: https://t.co/4iQLyXFy9X
#AOAplus
AOA 2026: ACUVUE OASYS 1-Day for Astigmatism now covers up to 2.75D cylinder across 3,350 parameter combinations—the most of any key daily disposable toric brand. Available in the US and Canada this summer.
Read more: https://t.co/925M6mWjzq
#OptometrysMeeting#AOAplus
A 74-year-old patient with herpes zoster ophthalmicus progresses to superior orbital fissure syndrome—a rare complication seen in fewer than 10% of HZO cases. Barbara J. Fluder, OD walks through the workup and management, and the role of HZO vaccination counseling.
Link in bio.
@CDCgov data suggests 80–99% of contact lens wearers report at least one risky practice. #Ophthalmology resident Keely Likosky writes on why the gap lies not in patient knowledge, but in how lens hygiene education is structured and delivered.
Read more: https://t.co/qB4NINzl14
As #CataractAwarenessMonth begins, Optometry Times is highlighting the vital role optometrists play in cataract detection, education, and care coordination.
Follow along all month for expert perspectives and clinical insights.
https://t.co/hxnlodJSq9
In The Independent Advantage’s first season, conversations centered on how ODs can thoughtfully select and collaborate with MDs to protect and enhance patient trust and clinical outcomes.
In case you missed it, watch highlights from Season 1 here: https://t.co/ilM14UC4mQ
In this Q&A, Jessilin Quint, OD, MBA, MS, FAAO, shares strategies for improving adherence, building trust through patient communication, avoiding common treatment pitfalls, and more.
Read more: https://t.co/DfHACEIw21
"AC and DED are 2 of the most prevalent ocular surface disorders encountered in clinical practice," writes Rodolfo L. Rodriguez, OD, DipABO.
Read the article: https://t.co/ltAIsprBuW
Be on the lookout for episode 3 of From Paper to Clinic! On May 4, Drs Hamza Shah and Michael Twa's discussion on AI in eye care will go live on our website and all podcast players. In the meantime, get caught up on the latest episodes on our website: https://t.co/EVdVdGRcxk
Make the most of your weekend with practical, real-world insights at the Collaborative Care Symposium. Join CCS on May 2–3, 2026, to learn from world-renowned faculty about refractive surgery, patient selection, MIGS, dry eye, and more. Register now: https://t.co/0UmNx3WYeu
As women enter their 40s and 50s, many notice two profound shifts happening at once: the hormonal changes of perimenopause and menopause, and the onset of presbyopia and other vision changes.
Read more: https://t.co/1DxHzFROA9
Or watch the interview: https://t.co/1DxHzFROA9
Prevent Blindness has designated April as Women’s Eye Health and Safety Month. We are proud to support this initiative and highlight the voices shaping the future of care. Explore insights from female key opinion leaders whose recent work is featured on our platforms.
On International Guide Dog Day, we recognize the incredible role guide dogs play in supporting individuals with visual impairment.
Read our new article now: https://t.co/i7zbBW4m0L
Image credit: Suvi Satama
Noelle Whitestone, MHA, discussed a systemic review that examined global gender disparities in access to refractive eye care services.
Watch the interview: https://t.co/QBXJ9wSUmx
A new eye drop called motugivatrep ophthalmic suspension 0.3% (Avarept) has been released in Japan to treat DED. The approval and availability of this product introduce a new way to target the nerve pathways in the eye that cause discomfort.
Read more: https://t.co/QfEQa1gjHu
Researchers at the UPMC have developed an experimental “living eye drop” that uses a naturally occurring ocular bacterium to support corneal wound healing, according to a proof-of-concept study published March 5, 2026, in Cell Reports.
Read more: https://t.co/NgQFxk2wtm
Dry eye disease (DED) has long occupied a somewhat uneasy place in the cataract and refractive surgery workflow. It is acknowledged as a complicating factor but is often addressed reactively rather than strategically.
Read more: https://t.co/guHTZx1ZL3